Showing results (421-430 of 579) with videos related to

Sort By:
Pageof 58
Biomedicines|February 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue SarcomaWenjie Gong, Lei Wang, Maria-Luisa Schubert, et al.
Experimental Hematology & Oncology|June 12, 2020
Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytesLiqing Kang, Xiaowen Tang, Jian Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2015
KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype AXiaojin Wu, Yao Yao, Xiaojing Bao, et al.
Journal of Hematology & Oncology|September 4, 2016
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTFrancesco Saraceni, Myriam Labopin, Norbert-Claude Gorin, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 9, 2014
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in ChinaYuqian Sun, He Huang, Jing Chen, et al.
Frontiers in Oncology|October 6, 2023
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patientsWeiqin Yao, Haifei Yang, Hongying You, et al.
Frontiers in Immunology|July 11, 2022
Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter StudyMeiqing Lei, Yanming Zhang, Wenjing Jiao, et al.
Bone Marrow Transplantation|February 27, 2021
Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantationXiaowen Tang, Benigno C Valdez, Yunju Ma, et al.
Hematology (Amsterdam, Netherlands)|April 12, 2022
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphomaLihong Zhang, Haifei Yang, Chongsheng Qian, et al.
Biomarker Research|May 22, 2020
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myelomaLiqing Kang, Jian Zhang, Minghao Li, et al.
Pageof 58